Skip to main content
Premium Trial:

Request an Annual Quote

NIH Awards S2 Genomics $280K Tech Transfer Grant

NEW YORK (GenomeWeb) – S2 Genomics announced today that it has received a $280,000 Phase 1 Small Business Technology Transfer grant from the National Institutes of Health's Human Genome Research Institute.

S2 will use the funds to develop its Singulator system for automated preparation of single cells. The Singulator system includes single-use sample cartridges and reagents that allow researchers to quickly isolate cells or nuclei with minimal impact on the cellular transcriptome, the firm added.

The project is a collaboration with Roger Lasken and Richard Scheuermann of the J. Craig Venter Institute, S2 noted. The Singulator will be optimized for use in single-cell genomic DNA sequencing and RNA sequencing from single nuclei, methods that were first developed by the Lasken lab in 2005 and 2013. The prototype Singulator system will be field tested at JCVI and other sites.

"Current methods of cell isolation represent a significant bottleneck for researchers and lead to inconsistencies in the data," S2 Founder and CEO Stevan Jovanovich said in a statement. "The Singulator will standardize experimental workflows and optimize both the quantity and quality of viable cells or nuclei isolated from a variety of tissue types."

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.